201. Efficacy and Safety Study of Neu2000KWL for Acute Ischemic Stroke Patients Within 6 Hours of Onset (Salfaprodil)
- Author
-
Zhejiang Apeloa Jiayuan Pharmaceutical Co. Ltd., Subei People's Hospital of Jiangsu Province, The First Hospital of Jilin University, First Hospital of China Medical University, General Hospital of Shenyang Military Region, The First Affiliated Hospital of BaoTou Medical College, Xuanwu Hospital, Beijing, Peking University First Hospital, Peking University Third Hospital, Tianjin First Central Hospital, Tianjin Huanhu Hospital, Hebei Medical University Third Hospital, The Second Hospital of Hebei Medical University, Hebei General Hospital, Second Hospital of Shanxi Medical University, Shandong Provincial Hospital, Qilu Hospital of Shandong University, The First Affiliated Hospital of Soochow University, Nanjing PLA General Hospital, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai Minhang Central Hospital, First Affiliated Hospital of Zhejiang University, Second Affiliated Hospital, School of Medicine, Zhejiang University, First Affiliated Hospital of Wenzhou Medical University, Xiangya Hospital of Central South University, Guangzhou First People's Hospital, Second Affiliated Hospital of Guangzhou Medical University, Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University, Nanfang Hospital, Southern Medical University, First Affiliated Hospital of Jinan University, Tongji Hospital, The Central Hospital of Lishui City, Shanghai Pudong New Area People's Hospital, Inner Mongolia Baogang Hospital, Daqing Oil Field Hospital, and Yongjun Wang, Vice President of Tian Tan Hospital, Director of Neurology Center
- Published
- 2020